+Vote!
Business Wire (Free subscription) | 09/05/2008
CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the
1Vote!
Business Wire (Free subscription) | 09/04/2008
CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced that it
+Vote!
The Earth Times Online Newspaper (Free subscription) | 08/25/2008
CARLSBAD, Calif. - Invitrogen Corporation (NASDAQ:IVGN) today announced it has set the date for a special meeting of its shareholders, to consider the proposed acquisition of Applied Biosystems Inc. The special meeting of shareholders will be held on October 16, 2008, at 9 a.m., PT at
1Vote!
Business Wire (Free subscription) | 08/25/2008
CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN) today announced it has set the date for a special meeting of its shareholders, to consider the proposed acquisition of
+Vote!
Business Wire (Free subscription) | 08/19/2008
CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today the
1Vote!
Red Orbit (Free subscription) | 08/19/2008
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today the launch of its Dynabeads(R) MAX Legionella, which enables a unique process for targeting and concentrating legionella from environmental water samples.
+Vote!
Business Wire (Free subscription) | 08/04/2008
CARLSBAD, Calif. & BALTIMORE--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, and Lentigen
+Vote!
Business Wire (Free subscription) | 07/30/2008
CARLSBAD, Calif. & NOVATO, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, has
+Vote!
Red Orbit (Free subscription) | 07/31/2008
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, has licensed an engineered stem cell line from the Buck Institute for Age Research.
+Vote!
Business Wire (Free subscription) | 07/24/2008
CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN) today announced results for its second quarter ended June 30, 2008. Revenues for the second quarter were
+Vote!
Market Wire - Pharmaceuticals and Biotech (Free subscription) | 07/21/2008
CARLSBAD, CA (MARKET WIRE) Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics, and Active Motif, Inc., developer of TimeLogic(R) hardware-accelerated genomics solutions, have announced a joint project to explore the use of field programmable gate array (FPGA) technology for the analysis of next-generation sequencing data....
+Vote!
The Earth Times Online Newspaper (Free subscription) | 07/21/2008
CARLSBAD, CA -- 07/21/08 -- Invitrogen Corporation, a provider of essential life science technologies for research, production and diagnostics, and Active Motif, Inc., developer of TimeLogic® hardware-accelerated genomics solutions, have annou..
+Vote!
Business Wire (Free subscription) | 09/03/2008
Applied Biosystems Inc. (formerly known as Applera Corporation) is a global leader in the development and marketing of instrument-based systems, consumables, software, and services for academic research, the life science industry and commercial markets. Driven by its employees' belief in the power of science to improve the human condition, the company commercializes innovative technology solutions...
1Vote!
Business Wire (Free subscription) | 08/28/2008
Applied Biosystems Inc. (formerly known as Applera Corporation) is a global leader in the development and marketing of instrument-based systems, consumables, software, and services for academic research, the life science industry and commercial markets. Driven by its employees' belief in the power of science to improve the human condition, the company commercializes innovative technology solutions...